Physician profile
Edwin P Su
NPI 1356459093
$13,164,576.92
in general payments reported to CMS, 2019-2025
15 companies · $669K in 2025
The $669K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97K · 2020: $43K · 2021: $637K · 2022: $10M · 2023: $1.0M · 2024: $267K · 2025: $669K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $1.2M · Royalty Or License: $621K · Consulting Fee: $75K · Travel and Lodging: $37K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Honoraria: $4,500 · Food and Beverage: $2,568 · Education: $554 · Other payment types: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $1,199,544.08 |
| Royalty Or License | $621,430.02 |
| Consulting Fee | $74,965.00 |
| Travel and Lodging | $37,283.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,850.00 |
| Honoraria | $4,500.00 |
| Food and Beverage | $2,567.86 |
| Education | $554.07 |
| Other payment types | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12,086,266.32 | 2019-2025 | Engage Partial Knee System, Or3o Dual Mobility, R3 Acetabular |
| Encore Medical, Lp | $583,054.55 | 2021 | |
| Uoc USA INC | $306,143.90 | 2019-2025 | Conformity, U-Motion II, Momentum |
| Orthalign INC | $186,835.65 | 2019-2025 | Orthalign Plus |
| Zimmer Biomet Holdings, INC. | $943.77 | 2025 | Oxford |
| Engage Uni, LLC | $446.96 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $217.23 | 2021-2022 | |
| Medtronic USA, INC. | $177.68 | 2019 | |
| Exsomed Corporation | $173.84 | 2019-2021 | |
| Medical Device Business Services, INC. | $142.70 | 2025 | Velys |
| Exactech, INC. | $122.34 | 2022 | |
| Stryker Corporation | $19.29 | 2025 | Mako |
| Overture Orthopaedics | $18.53 | 2025 | Overtureti |
| Innovation Technologies INC | $14.16 | 2024 | Irrisept |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$16,155,945.09 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.